- Credit Type: CME
- Credit Amount: 2.50
- Cost: Free
- Release: Sep 12, 2014
- Expires: Sep 12, 2017
- Estimated Time to Complete:
2 Hour(s) , 30 Minutes
- System Requirements:
Average User Rating:
Professor of Ophthalmology
Director, Ophthalmic Pathology Laboratory and Uveitis Service
University of Southern California
Los Angeles, CA
Director, Uveitis/Ocular Inflammatory Disease Service
Professor of Ophthalmology and Pathology
Director Ophthalmology Residency Program
University of Alabama-Birmingham
Needs StatementThe pathophysiology of Vogt-Koyanagi-Harada (VKH) disease remains unclear, yet many features specific to its natural history are known. Moreover, there is controversy among uveitis specialists over best treatment practice with regards to route and type of immunosuppression. In this event, we will address both the basic and clinical science that has provided our current foundation of knowledge for this blinding disease.
Target AudiencePhysicians, clinical researchers, optometry students, residents, fellows and any healthcare professional interested in ophthamology
ObjectivesUpon completion of this activity particpants will be able to:
1. Describe the latest discoveries in early diagnosis of uveitis.
2. Review the stages. epidemiloyg and pathophysiology of Uveitis.
3. Discuss prognosis and treatment options of uveitis.
The University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Kentucky College of Medicine designates this enduring material for a maximum of 2.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.
- Patient care
- Medical knowledge
Faculty DisclosureNarsing Rao, MD (speaker) has no relevant financial relationships with commercial interests.
Dr. Rao does not intend to discuss the off-label use of a product.
Russell Read, MD (speaker) has no relevant financial relationships with commercial interests.
Dr. Read does not intend to discuss the off-label use of a product.
No planners or content reviewers have any relevant financial relationships to disclose.
Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.